PMID: 11932361Apr 5, 2002Paper

Dose-intensive chemotherapy with syngeneic peripheral blood stem cell support for poor risk germ cell tumor of extragonadal origin: a case report

Japanese Journal of Clinical Oncology
Takashi KobayashiTatsuo Ichinohe

Abstract

A variety of regimens of high-dose chemotherapy with hematopoietic stem cell support for poor risk germ cell tumors have been established. However, a series of chemotherapy steps carried out prior to the harvest sometimes leads to an insufficient number of peripheral blood stem cells. Here, we report a case of a patient who successfully underwent high-dose chemotherapy for the treatment of poor risk extragonadal germ cell tumor by receiving peripheral blood stem cell transplantation donated from his genomically identical twin brother.

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

International Journal of Urology : Official Journal of the Japanese Urological Association
Masafumi KumanoMasato Fujisawa
International Journal of Urology : Official Journal of the Japanese Urological Association
K NamikiM Furusato
The Annals of Thoracic Surgery
Chih-Hao ChenHung-Chang Liu
European Urology
J J de la Rosette, F M Debruyne
© 2022 Meta ULC. All rights reserved